David Allison, MD
Vascular & Interventional Radiology · Stockbridge, GANPI 1386869535
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.7%), other and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Angiodynamics, Inc. at 51.6% of the total.
Across 282 payments — averaging $66.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$10K
- Penumbra, Inc.$3K
- W. L. Gore & Associates, Inc.$1K
- Bard Peripheral Vascular, Inc.$1K
- Johnson & Johnson$712
- Boston Scientific$580
- plus $2K from 24 others
What the payments were for
- Travel & lodging$1,3907%
- Food & beverage$7,85742%
- Education$3,21017%
- Other$6,40034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 13 | $9,727 |
| Penumbra, Inc. | 20 | $3,120 |
| W. L. Gore & Associates, Inc. | 58 | $1,358 |
| Bard Peripheral Vascular, Inc. | 49 | $1,218 |
| Johnson & Johnson | 42 | $712 |
| Boston Scientific | 16 | $580 |
| Endologix LLC | 3 | $339 |
| Inari Medical, Inc. | 8 | $272 |
| Pfizer | 10 | $244 |
| Medtronic(2 entities) | 15 | $235 |
| Philips North America LLC | 8 | $229 |
| Cardiovascular Systems Inc. | 7 | $160 |
| Cook Medical LLC | 7 | $122 |
| Tactile Systems Technology Inc | 5 | $87 |
| Abbott | 4 | $82 |
| Stryker | 1 | $72 |
| Argon Medical Devices, Inc. | 2 | $41 |
| Veryan Medical Incorporated | 1 | $31 |
| Cordis US CORP. | 2 | $30 |
| Baxter Healthcare | 1 | $27 |
| Imperative Care, Inc | 1 | $27 |
| Lemaitre Vascular, Inc. | 1 | $23 |
| Portola Pharmaceuticals, LLC | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $18 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Aroa Biosurgery Incorporated | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $14 |
| EKOS Corporation | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$8,000
- Indigo System$2,503
- EVLT$1,610
- Alto Abdominal Stent Graft System$328
- GORE VIABAHN VBX Balloon Expandable Endo$252
- COVERA$148
- Penumbra System$148
- Smart Coil$147
- GENERAL ATHERECTOMY$145
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$129
- VIABAHN VBX Balloon Expandable Endoprosthesis$127
- RUBY Coil$124
- VENOVO$110
- GENERAL VASCULAR INTERVENTION$106
How this compares
$18,857 in reported general payments places this provider in the 85th percentile of 120 vascular & interventional radiology providers in Georgia.
See all vascular & interventional radiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 89 | $72,431 |
| XareltoRivaroxaban | 39 | $38,927 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 82 | $911 |
| Ondansetron OdtOndansetron | 61 | $385 |
| ClopidogrelClopidogrel Bisulfate | 59 | $307 |
| Cilostazol | 24 | $212 |
| Tizanidine Hcl | 78 | $200 |
| Pentoxifylline | 19 | $197 |
| Methylprednisolone | 11 | $36 |
| Tramadol Hcl | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $244 | $72,43189 claims |
| Johnson & JohnsonXarelto | $712 | $38,92739 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 120 vascular & interventional radiology providers in Georgia.
Other vascular & interventional radiology in Stockbridge
- Sachin ShethStockbridge$46K
- David PennStockbridge$16K
- Charles GillilandStockbridge$15K
- Ayman AbunimerStockbridge$4K
- Nima KokabiAtlanta$1M
- Jason LevyAtlanta$822K
- Aravind ArepallyAtlanta$249K
- Kei YamadaAtlanta$154K
- Charles TeeslinkAugusta$135K
- Kirema Garcia-ReyesAtlanta$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.